Genesis Drug Discovery & Development (GD3), a member of Genesis Global Group, acquires JSS Medical Research to expand its clinical services portfolio. Read More
Our New Fragment-To-Lead Drug Discovery Service Has Launched Visit the page to learn more and download the white paper
Nature publishes Bioblocks' collaborative paper presenting fragment-based technology. View the paper in Nature Communications Read a summary in Chemistry Community
BioBlocks is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3Having the right chemistry partner is a must for the complex journey of drug discovery.
Extend your team. Integrate with ours.
Having the right chemistry partner is a must for the complex journey of drug discovery.
Extend your team. Integrate with ours.
Skilled People
Skilled People
Technology
Technology
Value Proposition
Value Proposition
Contact Us
Contact Us